Migenix Inc
|
B.C. Research Building
3650 Wesbrook Mall
Vancouver, BC V6S 2L2
Canada |
| Tel: |
1/604 221-9666 |
| URL: |
http://www.migenix.com |
|
| Formerly known as: |
| Micrologix Biotech Inc. |
 |
| Primary Symbols & Exchanges: |
| MGI - Toronto |
| - Berlin-Bremen Stock Exchange |
| - Pink Sheets |
|
|
| Primary Industry: |
| Biotechnology |
|
|
SIC Industry Code:
|
|
NAICS Industry Code:
|
|
Thomson Financial Business Description:
| The Group's principal activity is to research, develop and commercialize drugs in the areas of infectious and degenerative diseases to advance therapy, improve health and enrich lives. The clinical programs include drug candidates for the treatment of chronic hepatitis C infections (Phase II), the prevention of catheter-related infections (Phase III), the treatment of neurodegenerative diseases (Phase I) and the treatment of dermatological diseases (Phase II). It operates in Canada and the United States. |
|
Alacra Alerts:
 
|
Receive alerts on the latest reports on Migenix Inc
Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.
|
|
